Price Alert

G1 Therapeutics Inc. (GTHX)

NASDAQ: GTHX · Real-Time Price · USD

7.16

0.01 (0.14%)

At close: Sep 17, 2024, 9:56 PM

G1 Therapeutics Statistics

Share Statistics

G1 Therapeutics has 52.76M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	52.76M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	38.21%
Shares Floating	39.15M
Failed to Deliver (FTD) Shares	98,073
FTD / Avg. Volume	4.4%

Short Selling Information

The latest short interest is 4.37M, so 0% of the outstanding shares have been sold short.

Short Interest	4.37M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.96

Valuation Ratios

The PE ratio is -3.29 and the forward PE ratio is 0.7. G1 Therapeutics's PEG ratio is 0.05.

PE Ratio	-3.29
Forward PE	0.7
PS Ratio	1.91
Forward PS	0.6
PB Ratio	4.46
P/FCF Ratio	-4.12
PEG Ratio	0.05

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for G1 Therapeutics.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.87, with a Debt / Equity ratio of 1.62.

Current Ratio	3.87
Quick Ratio	3.45
Debt / Equity	1.62
Debt / EBITDA	-1.47
Debt / FCF	-1.49
Interest Coverage	-3.94

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$825.11K
Profits Per Employee	$-479.67K
Employee Count	100
Asset Turnover	0.68
Inventory Turnover	0.58

Taxes

Income Tax	3.12M
Effective Tax Rate	-6.95%

Stock Price Statistics

The stock price has increased by 0.85% in the last 52 weeks. The beta is 1.68, so G1 Therapeutics's price volatility has been higher than the market average.

Beta	1.68
52-Week Price Change	0.85%
50-Day Moving Average	5.75
200-Day Moving Average	4.06
Relative Strength Index (RSI)	84.39
Average Volume (20 Days)	2,229,441

Income Statement

In the last 12 months, G1 Therapeutics had revenue of 82.51M and earned -47.97M in profits. Earnings per share was -0.93.

Revenue	82.51M
Gross Profit	75.32M
Operating Income	-39.53M
Net Income	-47.97M
EBITDA	-39.01M
EBIT	-34.81M
Earnings Per Share (EPS)	-0.93

Full Income Statement

Balance Sheet

The company has 32.28M in cash and 57.17M in debt, giving a net cash position of -24.89M.

Cash & Cash Equivalents	32.28M
Total Debt	57.17M
Net Cash	-24.89M
Retained Earnings	-779.99M
Total Assets	98.69M
Working Capital	55.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -38.34M and capital expenditures 0, giving a free cash flow of -38.34M.

Operating Cash Flow	-38.34M
Capital Expenditures	n/a
Free Cash Flow	-38.34M
FCF Per Share	-0.74

Full Cash Flow Statement

Margins

Gross margin is 91.28%, with operating and profit margins of -47.91% and -58.13%.

Gross Margin	91.28%
Operating Margin	-47.91%
Pretax Margin	-54.36%
Profit Margin	-58.13%
EBITDA Margin	-47.28%
EBIT Margin	-47.91%
FCF Margin	-46.46%

Dividends & Yields

GTHX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for GTHX.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-8.17
Piotroski F-Score	2